Efficacy of Brazilian green propolis (EPP-AF®) as an adjunct treatment for hospitalized COVID-19 patients: A randomized, controlled clinical trial - Concepedia

Concepedia

Publication | Open Access

Efficacy of Brazilian green propolis (EPP-AF®) as an adjunct treatment for hospitalized COVID-19 patients: A randomized, controlled clinical trial

DOI Full Paper Access

117

Citations

44

References

2021

Year

Marcelo Augusto Duarte Silveira, David De Jong, Andresa Aparecida Berretta, Erica Batista dos Santos Galvão, Juliana Caldas, Thiago Cerqueira‐Silva, Thais Chaves Amorim, Marcel Miranda Dantas Gomes, Maurício Brito Teixeira, Sérgio Pinto de Souza,

Biomedicine & Pharmacotherapy

Abstract

Addition of propolis to the standard care procedures resulted in clinical benefits for the hospitalized COVID-19 patients, especially evidenced by a reduction in the length of hospital stay. Consequently, we conclude that propolis can reduce the impact of COVID-19.

References

	Year	Citations

Page 1